2015 AP, China & Japan TSIC Agenda
December 1st , 2015
12:00
18:00 - 21:00
(19:00 – 19:15)
Registration Desk Opens
Welcome Reception
Welcome Address (KH)
December 2nd, 2015
06:30 - 08:00
08:15 - 08:35
08:35 - 08:50
08:50 - 09:00
09:00 - 09:30
09:30 - 10:00
10:00 - 10:30
10:30 - 11:00
11:00 - 11:30
11:30 - 12:00
12:00 - 13:30
13:30 - 15:30
15:30 - 16:00
16:00 - 16:30
16:30 - 17:00
17:00 - 18:30
19:00
19:45
Breakfast
Welcome Address by IFCC
(Ferrari), APFCB(Frank),
Abbott(Beshiri)
Open Remarks (Sakamoto)
Day One Program Overview (Chair
Ferrari),
Keynote Speech
Plenary 1
Break and Posters
Plenary 2
Plenary 3
Plenary 4
Lunch / Innovation Workshop
Clinical/Scientific Workshops
Break and Posters
Plenary 5
Plenary 6
Innovation Workshop
Transfer to Dinner
Cultural Evening
Event and Dinner
December 3rd, 2015
07:00 - 08:15
07:15 - 08:15
08:30 - 08:45
08:45 - 09:45
09:45 - 10:30
10:30 - 12:30
12:30 - 14:00
14:00 - 14:30
14:30 – 15:00
15:00 – 16:30
17:00
18:00
Breakfast
KR & JPN Peer to Peer Exchanges
Recap & Day Two (Chair, Frank)
Program Overview
Peer to Peer Exchanges
Break and Posters
Clinical/Scientific Workshops
Lunch / Innovation Workshop
Plenary 7
Closing Commentaries
(Lam)
Innovation Workshop
Evening Departures
Small Group Dinners
December 4th, 2015
Final Departures
Association Involvements
IFCC:
Prof. Maurizio Ferrari, Ph.D., FAACB, FFSc(RCPA), President of IFCC,
APFCB:
Dr. Elizabeth Frank, M.D., Ph.D., APFCB Executive Board Treasurer.
2015 TSIC Theme
Elevating the Standard of Care
Keynote Speech and Plenary Session
P4 Medicine: Predictive, Preventative, Personalized and
Participatory
Maurizio Ferrari, PhD, FAACB, FFSc(RCPA), President of IFCC
Guidelines for HbA1c in the Diagnosis and Management of
Diabetes
Elizabeth Frank, M.D., Ph.D., APFCB Executive Board
IRIDICA: Transforming the management of Sepsis
David Brealey, Ph.D., MRCP, FRCA, FFICM, Consultant Lead for
Critical Care Trials, University College Hospital, London, UK
Privatization of Pathology
Peter Flett, RFD, MBBS, MAACB, FRCPA, Adj/Prof, School of
Pathology and Laboratory Medicine, The University of
Western Australia, Australia
Plenary Sessions
Leveraging Informatics for Improved Clinical Decision Making
Glenn Edwards, MBBS, MAACB, MD, FRCPA, FACHI., National
Medical Director Pathology, St. John of God Pathology, Australia
hsTnI: Advancing the Management of ACS Patients
Martin Than, MBBS., FFAEM., FACEM., Director of Emergency
Medicine Research, Christchurch Public Hospital, New Zealand
Enhancing Patient Care with HEOR
Sarina Fisher, The Centre for International Economics, Australia
30 Years of HIV Diagnostics
John Hackett, Ph.D., Head, Diagnostics Research, Abbott Diagnostics
Clinical Workshop Day 1–ACS Management
(December 2nd)
Chair: Jaganathan Sickan
Experiences with High-Sensitivity Troponins in NZ
Martin Than, Director of Emergency Medicine Research, Christchurch
Public Hospital, New Zealand
 hsTnI in the Emergency Department
Fred Korley, Johns Hopkins Medical Institutes, Department of
Emergency Medicine, Baltimore, Maryland, USA
Clinical Workshop Day 2 – Challenges in Emergency
Medicine (December 3rd)
Chair: Jaganathan Sickan
Biomarker Panels for Emergency Medicine
Peter Flett, RFD, MBBS, MAACB, FRCPA, Adj/Prof, School of
Pathology and Laboratory Medicine, The University of Western Australia,
Australia
IRIDICA: Clinical Study
David Brealey, Ph.D., MRCP, FRCA, FFICM, Consultant Lead for
Critical Care Trials, University College Hospital, London, UK
Scientific Workshop1– Quality of Clinical Chemistry
Chair: Carl Shiu / Andrew Soh
Implementation of Westgard Six Sigma Verification Program at
BIH
Navapun Charuruks, M.D., F.R.C. Path. Division Director, Laboratory
Division, Bumrungrad International Hospital, Bangkok, Thailand
The Latest American Guideline on the Treatment of Blood
Cholesterol – Is it More Confusing?
Leslie Lam, MBBS, DipRCPath, DABCC, MAACB, FACB, FRCPath,
FAMS, Laboratory Medicine, Ng Teng Fong General Hospital, Singapore
Enzymes and Traceability
David Armbruster, Ph.D., DABCC, FACB, Director, Clinical Chemistry
Marketing, Abbott Laboratories, USA
Scientific Workshop 2- Oncology Disease
Management
Chair: Maurizio Ferrari / Zheng Yijie
Lung Cancer Biomarker Panel (Dec 2nd)
Bai Chunxue, M.D., Professor, Zhongsan Hospital, China
Liquid biopsy: a new trend in cancer diagnostics (Dec 3rd)
Maurizio Ferrari, PhD, FAACB, FFSc(RCPA), President of IFCC
 PIVKA II Biomarker for Hepatocellular Carcinoma
Asahina Yasuhiro, M.D., Ph.D., Professor, Tokyo Medical and Dental
University, Japan
Serum Pepsinogen Levels to Diagnose H. pylori - Associated
Gastritis
Zhuping Fan, M.D., China
Scientific Workshop 3: Women’s Health
Chair: Anh Tran
Active B12 Deficiency in Women
Barnali Das, M.D., DNB, PGDM, Kokilaben Dhirubhai Ambani Hospital &
Medical Research Institute, India & Member IFCC C-STFT &
Corresponding Member, IFCC C-RIDL
Updates on Screening for Thyroid Disorders in Pregnancy
Walfrido Sumpaico, , Secretary General Asia & Oceania Federation of
Ob & Gyn
Vitamin D and Osteoporosis in India
Aparna Jairam, M.D., Head of Laboratory, SRL Laboratory, India
Scientific Workshop 4: Hematology
Chair: Haiyoung Jung
Triaging Microcytic Anemia using Extended RBC Parameters from
Automated Hematology Analyzer
Eloisa Urrechaga, MD., Dept. of Hematology, Galdako Usansolo
Hospital, Spain
Limitations of Automated Platelet Count Methods and Potential
Effect On Decisions Regarding Platelet Transfusions
Steven Marionneux, M.D., Memorial Sloane Kettering Cancer Center,
New York, USA
Hemostasis & Coagulation
Larry Smith, M.D., Abbott Laboratories, USA
Peer to Peer Exchanges (December 3rd only)
Informatics
Accreditation & Compliance
Hematology
Informatics for the
Laboratory
Karan Arora, Abbott
Laboratories, USA
Implementation of Quality Processes
and Achieving Accreditation
Elizabeth Frank, Learning 2 Lead
Consultants, India
IT Solutions for Accreditation and
Compliance
Munender Soperna, Dr Lal PathLabs,
India
Ting Yu, Abbott Laboratories, USA
Clinical Laboratory
Issues
Japanese Session
Korean Session
Small to Medium
Process
Improvements in
Clinical Laboratory
Rajesh Bendre,
Metropolis
Healthcare Ltd, India
New Market Opportunity with NGAL
and PG
Abbott Japan
Subclinical thyroid dysfunction and BMD
Min-Jung Kwon, M.D., Korea
Diagnostic System for HIV Infection in
Ehime University Hospital
Tatsuya Nishimiya, Division Director,
Ehime University Hospital, Japan
CELL-DYN Sapphire CD61
Immunoplatelet Method
Kwang Sook Woo, M.D., Korea
Abbott hsTnI levels in Korean
patients with chest pain
Hyung Doo Park, M.D., Korea
Positive rate of toxoplasma IgG and IgM
in Korean pregnant women
So-Yeon Seo, M.D., Korea
Additional Features
Scientific Posters:
from Abbott and attendees
Innovation Workshop
Company
Confidential
© 2011 Abbott